8 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... points: Active bleeding ... #Management #VTE ... #DVT #Algorithm ... #Venous #Thromboembolism
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... = venous thromboembolism ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Superficial - Active Bleeding ... Superficial #Deep #VTE ... #DVT #Hematology ... Management #Anatomy #Anticoagulation ... #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism ... Treatment Algorithm ... therapy - Second VTE ... management #hematology #anticoagulation
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
the Treatment of Cancer-Associated ... Venous Thromboembolism ... respect to recurrent VTE ... VenousThromboembolism #VTE ... VisualAbstract #DVT
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... Thromboembolic ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... Considerations • Thromboembolic ... suggest prophylactic anticoagulation ... teratogenic GDMT meds ... Serial TTE and close